These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5789008)

  • 41. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of ophthalmic solutions: modern concepts. I. Atropine sulphate.
    KEDVESSY G; DE GROSZ S; SZEPESY A
    Br J Ophthalmol; 1950 Apr; 34(4):228-34. PubMed ID: 15411486
    [No Abstract]   [Full Text] [Related]  

  • 43. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the stability of injectable L-ascorbic acid solutions. I. Effect of pH, solvent, light and container.
    Kassem MA; Kassem AA; Ammar HO
    Pharm Acta Helv; 1969 Oct; 44(10):611-23. PubMed ID: 5354572
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antimicrobial safety of eye drops and their adjustment].
    Háze K; Dolezalová V
    Cesk Farm; 1981 Nov; 30(9):319-21. PubMed ID: 7317956
    [No Abstract]   [Full Text] [Related]  

  • 46. Validation of a radiosterilization procedure for sterilization of a solid-state ophthalmic insert system.
    Garfinkle B; Cochran J; Snyder J; Thrasher G; Thompson B; Orlowski S; Harwood RJ; Cohen EM
    J Parenter Sci Technol; 1985; 39(6):246-50. PubMed ID: 4093826
    [No Abstract]   [Full Text] [Related]  

  • 47. [Polymer-containing eye drops. II. Isotonicity and pH adjustment of polymer solutions].
    Ugriné-Hunyadvári E; Kissné Koczka C
    Acta Pharm Hung; 1995 Jan; 65(1):15-21. PubMed ID: 7725925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Open drops in ophthalmology offices: expiration and contamination.
    Wessels IF; Bekendam P; Calvin WS; Zimmerman GJ
    Ophthalmic Surg Lasers; 1999; 30(7):540-6. PubMed ID: 10929977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The sterilization of ophthalmic solutions].
    Pănescu C
    Oftalmologia; 1991; 35(1):69-74. PubMed ID: 1811743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The stability of adrenaline ophthalmic solutions on sterilization and storage.
    Sixsmith DG; Watkins WM; Kokwaro GO
    J Clin Hosp Pharm; 1982 Sep; 7(3):205-7. PubMed ID: 7174836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An outline for preparing ophthalmic solutions.
    Cadwallader DE
    Am J Hosp Pharm; 1967 Jan; 24(1):32-6. PubMed ID: 6016342
    [No Abstract]   [Full Text] [Related]  

  • 52. [Annotations on the Belgian Pharmacopeia, 5th edition].
    Deltombe J
    Farmaco Prat; 1969 Jan; 24(1):3-35. PubMed ID: 5779030
    [No Abstract]   [Full Text] [Related]  

  • 53. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization].
    Pawlaczyk J; Nowacka D
    Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998
    [No Abstract]   [Full Text] [Related]  

  • 54. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On the thermic stability of drug solutions].
    Speiser P
    Pharm Acta Helv; 1968 Nov; 43(11):693-703. PubMed ID: 4888331
    [No Abstract]   [Full Text] [Related]  

  • 56. Some physico-chemical properties micelle--benzalkonium chloride (BAC) adduct on interface in selected eye drops.
    Zawadzka E; Stefański P; Zgoda MM
    Acta Pol Pharm; 1995; 52(4):275-9. PubMed ID: 8960257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Contribution to the stability of papaverine. Part 6: The stability of aqueous solutions of papaverine hydrochloride (author's transl)].
    Gundermann P; Pohloudek-Fabini R
    Pharmazie; 1980 Dec; 35(12):764-6. PubMed ID: 7208577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A simple apparatus for the sterilization of eye drops using filtration].
    Allart HH
    Pharm Weekbl; 1969 Jun; 104(24):492-3. PubMed ID: 5783701
    [No Abstract]   [Full Text] [Related]  

  • 59. [Analysis and stability of suxamethonium chloride. 2: Study of various factors in the stability of suxamethonium chloride injection solutions].
    Kottke D; Döge G; Pohloudek-Fabini R
    Pharmazie; 1983 Jun; 38(6):377-8. PubMed ID: 6611640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Thio-tepa" eye drops.
    Foster J
    Trans Aust Coll Ophthalmol; 1970; 2():32-3. PubMed ID: 5004192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.